JP2010059117A - Skin lotion - Google Patents
Skin lotion Download PDFInfo
- Publication number
- JP2010059117A JP2010059117A JP2008228041A JP2008228041A JP2010059117A JP 2010059117 A JP2010059117 A JP 2010059117A JP 2008228041 A JP2008228041 A JP 2008228041A JP 2008228041 A JP2008228041 A JP 2008228041A JP 2010059117 A JP2010059117 A JP 2010059117A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- group
- acid
- lotion
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000006210 lotion Substances 0.000 title claims abstract description 36
- -1 dicarboxylic acid ester Chemical class 0.000 claims abstract description 37
- 229920001296 polysiloxane Polymers 0.000 claims abstract description 17
- 150000002148 esters Chemical class 0.000 claims abstract description 13
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims abstract description 10
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 7
- 230000000694 effects Effects 0.000 abstract description 13
- 230000003020 moisturizing effect Effects 0.000 abstract description 9
- 239000004721 Polyphenylene oxide Substances 0.000 abstract description 5
- 229920000570 polyether Polymers 0.000 abstract description 5
- 229910052731 fluorine Inorganic materials 0.000 abstract description 3
- 239000011737 fluorine Substances 0.000 abstract description 3
- 239000000470 constituent Substances 0.000 abstract 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- XLYOFNOQVPJJNP-DYCDLGHISA-N deuterium hydrogen oxide Chemical compound [2H]O XLYOFNOQVPJJNP-DYCDLGHISA-N 0.000 abstract 1
- 238000009499 grossing Methods 0.000 abstract 1
- 239000000284 extract Substances 0.000 description 35
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- HQHCYKULIHKCEB-UHFFFAOYSA-N tetradecanedioic acid Chemical compound OC(=O)CCCCCCCCCCCCC(O)=O HQHCYKULIHKCEB-UHFFFAOYSA-N 0.000 description 10
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 8
- 239000002202 Polyethylene glycol Substances 0.000 description 7
- 125000000217 alkyl group Chemical group 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 7
- 229920001223 polyethylene glycol Polymers 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- CBFCDTFDPHXCNY-UHFFFAOYSA-N icosane Chemical compound CCCCCCCCCCCCCCCCCCCC CBFCDTFDPHXCNY-UHFFFAOYSA-N 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- PVNIIMVLHYAWGP-UHFFFAOYSA-N nicotinic acid Natural products OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 238000002834 transmittance Methods 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 4
- 238000007259 addition reaction Methods 0.000 description 4
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 4
- 230000003301 hydrolyzing effect Effects 0.000 description 4
- 150000001282 organosilanes Chemical class 0.000 description 4
- 229940113116 polyethylene glycol 1000 Drugs 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 125000000753 cycloalkyl group Chemical group 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- JJOJFIHJIRWASH-UHFFFAOYSA-N icosanedioic acid Chemical compound OC(=O)CCCCCCCCCCCCCCCCCCC(O)=O JJOJFIHJIRWASH-UHFFFAOYSA-N 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- 239000011664 nicotinic acid Substances 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 229940109850 royal jelly Drugs 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 238000001308 synthesis method Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- 239000002211 L-ascorbic acid Substances 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 229940069521 aloe extract Drugs 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 229950004580 benzyl nicotinate Drugs 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 229940062933 dimethylsilanol hyaluronate Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000005923 long-lasting effect Effects 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229920006136 organohydrogenpolysiloxane Polymers 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 2
- 229940057847 polyethylene glycol 600 Drugs 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229960003471 retinol Drugs 0.000 description 2
- 235000020944 retinol Nutrition 0.000 description 2
- 239000011607 retinol Substances 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- 229960001722 verapamil Drugs 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- 229960001296 zinc oxide Drugs 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 description 1
- WRGQSWVCFNIUNZ-GDCKJWNLSA-N 1-oleoyl-sn-glycerol 3-phosphate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)COP(O)(O)=O WRGQSWVCFNIUNZ-GDCKJWNLSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical class C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- NPQPNSNHYJTUSA-UHFFFAOYSA-N 3-ethyloctan-3-ol Chemical compound CCCCCC(O)(CC)CC NPQPNSNHYJTUSA-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- IELOKBJPULMYRW-IKTKBOKFSA-N 4-oxo-4-[[(2S)-2,5,7,8-tetramethyl-2-[(4S,8S)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl]oxy]butanoic acid Chemical compound CC(C)CCC[C@H](C)CCC[C@H](C)CCC[C@@](C)(CC1)Oc(c(C)c2C)c1c(C)c2OC(CCC(O)=O)=O IELOKBJPULMYRW-IKTKBOKFSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 244000104272 Bidens pilosa Species 0.000 description 1
- 235000010662 Bidens pilosa Nutrition 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- 208000035699 Distal ileal obstruction syndrome Diseases 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 240000000731 Fagus sylvatica Species 0.000 description 1
- 235000010099 Fagus sylvatica Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000006000 Garlic extract Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 235000003368 Ilex paraguariensis Nutrition 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 235000011203 Origanum Nutrition 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- MJNIWUJSIGSWKK-BBANNHEPSA-N Riboflavin butyrate Chemical compound CCCC(=O)OC[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)CN1C2=CC(C)=C(C)C=C2N=C2C1=NC(=O)NC2=O MJNIWUJSIGSWKK-BBANNHEPSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- PAUSGZCRNOTKPK-UHFFFAOYSA-N [5-hydroxy-6-methyl-4-(octanoyloxymethyl)pyridin-3-yl]methyl octanoate Chemical compound CCCCCCCC(=O)OCC1=CN=C(C)C(O)=C1COC(=O)CCCCCCC PAUSGZCRNOTKPK-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002280 anti-androgenic effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- 229940030495 antiandrogen sex hormone and modulator of the genital system Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 239000010426 asphalt Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- SWQUTKGVXGTROS-UHFFFAOYSA-N bis(2-ethoxyethyl) butanedioate Chemical compound CCOCCOC(=O)CCC(=O)OCCOCC SWQUTKGVXGTROS-UHFFFAOYSA-N 0.000 description 1
- 238000012661 block copolymerization Methods 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 229940007061 capsicum extract Drugs 0.000 description 1
- 239000001943 capsicum frutescens fruit extract Substances 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- DERZBLKQOCDDDZ-JLHYYAGUSA-N cinnarizine Chemical compound C1CN(C(C=2C=CC=CC=2)C=2C=CC=CC=2)CCN1C\C=C\C1=CC=CC=C1 DERZBLKQOCDDDZ-JLHYYAGUSA-N 0.000 description 1
- 229960000876 cinnarizine Drugs 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 108010006161 conchiolin Proteins 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 239000001599 crocus sativus l. flower extract Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 229940119676 diethoxyethyl succinate Drugs 0.000 description 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical compound [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229940124274 edetate disodium Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000020706 garlic extract Nutrition 0.000 description 1
- 235000020708 ginger extract Nutrition 0.000 description 1
- 229940002508 ginger extract Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229940038487 grape extract Drugs 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229960005436 inositol nicotinate Drugs 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 108010028309 kalinin Proteins 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000020331 mate tea Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- AHXDSVSZEZHDLV-UHFFFAOYSA-N mesulfen Chemical compound CC1=CC=C2SC3=CC(C)=CC=C3SC2=C1 AHXDSVSZEZHDLV-UHFFFAOYSA-N 0.000 description 1
- 229960005479 mesulfen Drugs 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- MFZCIDXOLLEMOO-GYSGTQPESA-N myo-inositol hexanicotinate Chemical compound O([C@H]1[C@@H]([C@H]([C@@H](OC(=O)C=2C=NC=CC=2)[C@@H](OC(=O)C=2C=NC=CC=2)[C@@H]1OC(=O)C=1C=NC=CC=1)OC(=O)C=1C=NC=CC=1)OC(=O)C=1C=NC=CC=1)C(=O)C1=CC=CN=C1 MFZCIDXOLLEMOO-GYSGTQPESA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 125000005010 perfluoroalkyl group Chemical group 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229940092288 polyethylene glycol 11000 Drugs 0.000 description 1
- 229940113115 polyethylene glycol 200 Drugs 0.000 description 1
- 229940068886 polyethylene glycol 300 Drugs 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 229940076591 saffron extract Drugs 0.000 description 1
- 229940112950 sage extract Drugs 0.000 description 1
- 235000020752 sage extract Nutrition 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 229940033504 soybean preparation Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- SHWIJIJNPFXOFS-UHFFFAOYSA-N thiotaurine Chemical compound NCCS(O)(=O)=S SHWIJIJNPFXOFS-UHFFFAOYSA-N 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- JIVZKJJQOZQXQB-UHFFFAOYSA-N tolazoline Chemical compound C=1C=CC=CC=1CC1=NCCN1 JIVZKJJQOZQXQB-UHFFFAOYSA-N 0.000 description 1
- 229960002312 tolazoline Drugs 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 108010021724 tonin Proteins 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 125000000725 trifluoropropyl group Chemical group [H]C([H])(*)C([H])([H])C(F)(F)F 0.000 description 1
- 239000008513 turmeric extract Substances 0.000 description 1
- 229940052016 turmeric extract Drugs 0.000 description 1
- 235000020240 turmeric extract Nutrition 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000009538 yokuinin Substances 0.000 description 1
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、化粧水に関し、更に詳細には、(A)ポリエーテル変性シリコーン、(B)ジカルボン酸のエステル、(C)アルキレングリコール、(D)水を含有し、べたつきがなく、肌の潤い感、なめらか感、すべり感に優れ、かつその効果が長時間持続する、透明性に優れた化粧水に関するものである。
The present invention relates to a skin lotion, and more specifically, contains (A) a polyether-modified silicone, (B) an ester of a dicarboxylic acid, (C) an alkylene glycol, (D) water, has no stickiness, and moisturizes the skin. The present invention relates to a skin lotion with excellent transparency, smoothness and slipperiness, which has a long-lasting effect and has excellent transparency.
従来、化粧水において、グリセリン、ソルビトール等の多価アルコール類、乳酸、クエン酸等の有機酸類、アミノ酸類を保湿剤として配合してきた。 Conventionally, in skin lotions, polyhydric alcohols such as glycerin and sorbitol, organic acids such as lactic acid and citric acid, and amino acids have been blended as moisturizers.
しかしながら、これらの保湿剤は少量では保湿効果を発揮することができず、また多量に配合すると肌にべたつきが生じるといった問題があった。べたつき感は化粧水の感触として嫌われる場合が多く、べたつかずに肌を潤す商品の開発が必要であった。そのため、多価アルコール等の他の保湿剤として、オリゴマーエステルを含有した化粧料(例えば、特許文献1参照)や肌のべたつきを抑えるために、例えばポリビニルアルコールを含有した化粧水(例えば、特許文献2参照)、ポリエーテル変性シリコーンを含有した化粧料(例えば、特許文献3参照)が開発されているが、いずれも不自然な肌のべたつきやぬるつきが生じるなど、使用感触に良好な感触が望まれる化粧水においては満足のいくものが得られなかった。 However, these humectants cannot exhibit a moisturizing effect in a small amount, and there is a problem that when they are added in a large amount, the skin becomes sticky. The sticky feeling is often disliked as the feeling of lotion, and it was necessary to develop a product that moisturizes the skin without stickiness. Therefore, as other moisturizing agents such as polyhydric alcohol, cosmetics containing oligomer esters (see, for example, Patent Document 1) and skin lotions containing, for example, polyvinyl alcohol (for example, Patent Documents) to suppress skin stickiness. 2), and cosmetics containing polyether-modified silicone (see, for example, Patent Document 3) have been developed, both of which have a good feel in use, such as unnatural skin stickiness and sliminess. The desired lotion was not satisfactory.
斯かる状況下、本発明の目的とするところは、べたつきがなく、肌の潤い感、なめらか感、すべり感に優れ、かつその効果が長時間持続する、透明性に優れた化粧水を提供することにある。 Under such circumstances, the object of the present invention is to provide a skin lotion that is non-sticky, excellent in moisturizing, smooth, and slippery, and has excellent transparency and has a long-lasting effect. There is.
即ち、本発明は(A)ポリエーテル変性シリコーン、(B)ジカルボン酸のエステル、(C)アルキレングリコール、(D)水を含有する化粧水である。そして(A)成分のポリエーテル変性シリコーンがフッ素ポリエーテル共変性シリコーンである事が好ましく、また(B)成分のジカルボン酸のエステルがポリグリセリンとのエステルであることが好ましい。 That is, the present invention is a lotion containing (A) a polyether-modified silicone, (B) an ester of dicarboxylic acid, (C) an alkylene glycol, and (D) water. The polyether-modified silicone as the component (A) is preferably a fluoropolyether co-modified silicone, and the dicarboxylic acid ester as the component (B) is preferably an ester with polyglycerol.
本発明は、ポリエーテル変性シリコーン、ジカルボン酸のエステル、アルキレングリコール、水を配合することで、べたつきがなく、肌の潤い感、なめらか感、すべり感に優れ、かつその効果が長時間持続する、透明性に優れた化粧水を提供できる。 By blending polyether-modified silicone, dicarboxylic acid ester, alkylene glycol, water, the present invention has no stickiness, moisturized skin, smooth feeling, smooth feeling, and the effect lasts for a long time. A lotion with excellent transparency can be provided.
以下、本発明の構成について詳述する。 Hereinafter, the configuration of the present invention will be described in detail.
本発明における(A)成分であるポリエーテル変性シリコーンは、一般式(1)で表さ
れ、単独、または2種以上を混合して用いることができる。
The polyether-modified silicone which is the component (A) in the present invention is represented by the general formula (1), and can be used alone or in admixture of two or more.
一般式(1)中において、R1基としては、例えば、メチル基,エチル基,プロピル基,ペンチル基,ヘキシル基,ヘプチル基,オクチル基,ノニル基,デシル基等のアルキル基、シクロペンチル基,シクロヘキシル基等のシクロアルキル基、フェニル基,トリル基等のアリール基が挙げられ、好ましくはメチル基を挙げることができる。尚、単一のものであっても、異なる基であってもかまわない。 In the general formula (1), examples of the R 1 group include methyl groups, ethyl groups, propyl groups, pentyl groups, hexyl groups, heptyl groups, octyl groups, nonyl groups, decyl groups and other alkyl groups, cyclopentyl groups, Examples thereof include cycloalkyl groups such as a cyclohexyl group, and aryl groups such as a phenyl group and a tolyl group, and a methyl group is preferable. It may be a single group or a different group.
R2基としては、例えば、トリフルオロプロピル基,ノナフルオロヘキシル基,ヘプタデカフルオロデシル基などの炭素数1〜10のフッ素置換アルキル基が挙げられ、好ましくは、ノナフルオロヘキシル基を挙げることができる。また、パーフルオロアルキル基でも、一部置換アルキル基でも同様に用いることができる。 Examples of the R 2 group include a fluorine-substituted alkyl group having 1 to 10 carbon atoms such as a trifluoropropyl group, a nonafluorohexyl group, and a heptadecafluorodecyl group, and preferably a nonafluorohexyl group. it can. Further, a perfluoroalkyl group or a partially substituted alkyl group can be used similarly.
R3基としては、一般式として−CpH2pO(C2H4O)a(C3H6O)bR5で表されるポリオキシアルキレン基である(ここでR5は水素原子、炭素数1〜5のアルキル基又はアセチル基であり、a、b、pは整数であって、aとbはいずれも0〜100、a+bは1以上であり、p=2〜6である)。 The R 3 group is a polyoxyalkylene group represented by the general formula —C p H 2p O (C 2 H 4 O) a (C 3 H 6 O) b R 5 (where R 5 is hydrogen). An atom, an alkyl group having 1 to 5 carbon atoms, or an acetyl group, a, b, and p are integers, a and b are each 0 to 100, a + b is 1 or more, and p = 2 to 6 is there).
例えばエチレンオキサイドのみからなる化合物(上記R3基を示す一般式においてb=0となるもの)として、−C3H6O(C2H4O)5H、−C3H6O(C2H4O)10H、−C3H6O(C2H4O)20H、−C3H6O(C2H4O)50H、−C3H6O(C2H4O)100H、−C3H6O(C2H4O)5CH3、−C3H6O(C2H4O)10C2H5、−C3H6O(C2H4O)20C3H7、−C3H6O(C2H4O)50C4H9、−C3H6O(C2H4O)100C5H11、−CH2CH(CH3)CH2O(C2H4O)3H、−CH2CH2CH(CH3)O(C2H4O)10CH3、−CH2CH2C(CH3)2O(C2H4O)20C4H9等が挙げられる。 For example, as a compound consisting only of ethylene oxide (in the general formula showing R 3 group, b = 0), —C 3 H 6 O (C 2 H 4 O) 5 H, —C 3 H 6 O (C 2 H 4 O) 10 H, -C 3 H 6 O (C 2 H 4 O) 20 H, -C 3 H 6 O (C 2 H 4 O) 50 H, -C 3 H 6 O (C 2 H 4 O) 100 H, —C 3 H 6 O (C 2 H 4 O) 5 CH 3 , —C 3 H 6 O (C 2 H 4 O) 10 C 2 H 5 , —C 3 H 6 O (C 2 H 4 O) 20 C 3 H 7, -C 3 H 6 O (C 2 H 4 O) 50 C 4 H 9, -C 3 H 6 O (C 2 H 4 O) 100 C 5 H 11, - CH 2 CH (CH 3) CH 2 O (C 2 H 4 O) 3 H, -CH 2 CH 2 CH (CH 3) O (C 2 H 4 O) 10 CH 3, -CH 2 CH 2 C (CH 3 ) 2 O (C 2 H 4 O) 20 C 4 H 9 and the like.
また、プロピレンオキサイドのみからなる化合物(上記R3基を示す一般式においてa=0となるもの)としては、例えば、−C3H6O(C3H6O)5H、−C3H6O(C3H6O)10H、−C3H6O(C3H6O)20H、−C3H6O(C3H6O)50H、−C3H6O(C3H6O)100H、−C3H6O(C3H6O)5CH3、−C3H6O(C3H6O)10C2H5、−C3H6O(C3H6O)20C3H7、−C3H6O(C3H6O)50C4H9、−C3H6O(C3H6O)100C5H11、−CH2CH(CH3)CH2O(C3H6O)3H、−CH2CH2CH(CH3)O(C3H6O)10CH3、−CH2CH2C(CH3)2O(C3H6O)20C4H9等が挙げられる。 Examples of the compound composed only of propylene oxide (the compound in which a = 0 in the general formula showing the R 3 group) include, for example, —C 3 H 6 O (C 3 H 6 O) 5 H, —C 3 H 6 O (C 3 H 6 O) 10 H, —C 3 H 6 O (C 3 H 6 O) 20 H, —C 3 H 6 O (C 3 H 6 O) 50 H, —C 3 H 6 O (C 3 H 6 O) 100 H, -C 3 H 6 O (C 3 H 6 O) 5 CH 3, -C 3 H 6 O (C 3 H 6 O) 10 C 2 H 5, -C 3 H 6 O (C 3 H 6 O) 20 C 3 H 7 , —C 3 H 6 O (C 3 H 6 O) 50 C 4 H 9 , —C 3 H 6 O (C 3 H 6 O) 100 C 5 H 11, -CH 2 CH (CH 3) CH 2 O (C 3 H 6 O) 3 H, -CH 2 CH 2 CH (CH 3) O (C 3 H 6 O) 10 CH 3, -CH 2 CH 2 C (CH 3 ) 2 O (C 3 H 6 O) 20 C 4 H 9 and the like can be mentioned.
エチレンオキサイド、プロピレンオキサイドの共重合体としては、例えば、−C3H6O(C2H4O)5(C3H6O)5H、−C3H6O(C2H4O)20(C3H6O)20H、−C3H6O(C2H4O)10(C3H6O)20CH3、−C3H6O(C2H4O)20(C3H6O)10CH3、−CH2CH(CH3)CH2O(C2H4O)50(C3H6O)20C4H9、−CH2CH2C
H(CH3)O(C2H4O)10(C3H6O)100H、−CH2CH2C(CH3)2O(C2H4O)100(C3H6O)10CH3等が挙げられる。ここでエチレンオキサイド単位とプロピレンオキサイド単位はブロック共重合でもランダム共重合でもかまわない。
As a copolymer of ethylene oxide and propylene oxide, for example, —C 3 H 6 O (C 2 H 4 O) 5 (C 3 H 6 O) 5 H, —C 3 H 6 O (C 2 H 4 O) ) 20 (C 3 H 6 O) 20 H, —C 3 H 6 O (C 2 H 4 O) 10 (C 3 H 6 O) 20 CH 3 , —C 3 H 6 O (C 2 H 4 O) 20 (C 3 H 6 O) 10 CH 3 , —CH 2 CH (CH 3 ) CH 2 O (C 2 H 4 O) 50 (C 3 H 6 O) 20 C 4 H 9 , —CH 2 CH 2 C
H (CH 3) O (C 2 H 4 O) 10 (C 3 H 6 O) 100 H, -CH 2 CH 2 C (CH 3) 2 O (C 2 H 4 O) 100 (C 3 H 6 O ) 10 CH 3 and the like. Here, the ethylene oxide unit and the propylene oxide unit may be block copolymerization or random copolymerization.
R4基は、R1、R2又はR3基のいずれかと同じである。 The R 4 group is the same as any of the R 1 , R 2 or R 3 groups.
R5基としては、水素原子、メチル基、エチル基、プロピル基、ブチル基、ペンチル基等のアルキル基またはアセチル基が挙げられる。 Examples of the R 5 group include a hydrogen atom, a methyl group, an ethyl group, a propyl group, a butyl group, an alkyl group such as a pentyl group, or an acetyl group.
これらの一般的な原料として、例えばSS−280xシリーズ、SH3771M(以上、東レ・ダウコーニング社製)、KF−6011、KF−351A、KF−354L、KF−355A、KF−640、KF−642、KF−643や、FPD−4668等のFPDシリーズ(以上、信越化学工業社製)等が挙げられる。 Examples of these general raw materials include SS-280x series, SH3771M (manufactured by Toray Dow Corning), KF-6011, KF-351A, KF-354L, KF-355A, KF-640, KF-642, Examples thereof include FPD series such as KF-643 and FPD-4668 (manufactured by Shin-Etsu Chemical Co., Ltd.).
さらに、一般式(1)で示される(A)成分の中でも、mが1以上である、フッ素ポリエーテル共変性シリコーンが好ましい。 Furthermore, among the component (A) represented by the general formula (1), fluorine polyether co-modified silicone having m of 1 or more is preferable.
本発明におけるフッ素ポリエーテル共変性シリコーンは、例えば、下記に示す特開平6−246144号公報に開示されている合成法によって得られるが、特にこれに限定されるものではない。 The fluoropolyether co-modified silicone in the present invention can be obtained by, for example, a synthesis method disclosed in JP-A-6-246144 shown below, but is not particularly limited thereto.
<合成方法1>
R1 3SiO1/2、R1 2SiO、R1R2SiO、R1R3SiO、(R1)(H)SiO、(H)(R1)2SiO1/2、R1 2R2SiO1/2、R1 2R3SiO1/2のシロキサン単位のうち、(R1)(H)SiO及び/または(H)(R1)SiO単位が必須になるようにしたシロキサンオリゴマー原料を組み合わせて再重合し、一般式(2)に示されるオルガノハイドロジェンポリシロキサンを得、これに CeH2e-1O(C2H4O)f(C3H6O)gR5、(以下、(i)式と略す)で示されるポリオキシアルキレンと、末端に二重結合を有するフッ素置換アルキル化合物を付加反応させて合成することができる。
<Synthesis Method 1>
R 1 3 SiO 1/2 , R 1 2 SiO, R 1 R 2 SiO, R 1 R 3 SiO, (R 1 ) (H) SiO, (H) (R 1 ) 2 SiO 1/2 , R 1 2 Among the siloxane units of R 2 SiO 1/2 and R 1 2 R 3 SiO 1/2 , the siloxane in which (R 1 ) (H) SiO and / or (H) (R 1 ) SiO units are essential. re polymerization by combining an oligomer raw material, the general formula to give the organohydrogenpolysiloxane represented in (2), which in C e H 2e-1 O ( C 2 H 4 O) f (C 3 H 6 O) g It can be synthesized by addition reaction of R 5 , polyoxyalkylene represented by (hereinafter abbreviated as formula (i)) and a fluorine-substituted alkyl compound having a double bond at the terminal.
但し、R6は水素原子、R1、R2またはR3である。 R 6 is a hydrogen atom, R 1 , R 2 or R 3 .
尚、ここで上記オルガノハイドロジェンシロキサンの代わりに一般式(3)で示すようなオルガノハイドロジェンシロキサンを得て、これに(i)式のポリオキシアルキレンを付加反応させて合成しても良いし、一般式(4)で示されるようなオルガノハイドロジェンポリシロキサンを得て、これに末端に二重結合を有するフッ素置換アルキル化合物を付加反応させても良い。 Here, instead of the organohydrogensiloxane, an organohydrogensiloxane as represented by the general formula (3) may be obtained, and this may be synthesized by addition reaction of the polyoxyalkylene of the formula (i). Alternatively, an organohydrogenpolysiloxane represented by the general formula (4) may be obtained, and this may be subjected to an addition reaction with a fluorine-substituted alkyl compound having a double bond at the terminal.
ここで一般式(2)〜(4)において、R1:アルキル基,シクロアルキル基,またはアリール基、R2:炭素数1〜10のフッ素置換アルキル基、R3:一般式−CpH2pO(C2H4O)a(C3H6O)bR5〔R5は水素原子、炭素数1〜5のアルキル基またはアセチル基、a,b,pは整数であり、a,b:0〜100、a+b≧1、p=2〜6〕から選ばれ、R4基はR1、R2またはR3のいずれかと同じである。l,m=0〜500、n=1〜500で示される。 Here, in the general formulas (2) to (4), R 1 : an alkyl group, a cycloalkyl group, or an aryl group, R 2 : a fluorine-substituted alkyl group having 1 to 10 carbon atoms, R 3 : a general formula —C p H 2p O (C 2 H 4 O) a (C 3 H 6 O) b R 5 [R 5 is a hydrogen atom, an alkyl group having 1 to 5 carbon atoms or an acetyl group, a, b, and p are integers, , B: 0 to 100, a + b ≧ 1, p = 2 to 6], and the R 4 group is the same as any one of R 1 , R 2 or R 3 . l, m = 0 to 500, and n = 1 to 500.
<合成方法2>
R1 3SiX、R1 2SiX2、R1R2SiX2、R1R3SiX2、(R1)(H)SiX2、(H)(R1)2SiX、R1 2R2SiX及びR1 2R3SiX(但し、XはCl、Br、I等のハロゲンあるいはメトキシ、エトキシ、プロポキシ基等のアルコキシ基である。)からなる群より選ばれ、(R1)(H)SiX2及び/または(H)(R1)2SiXを必須とするようなオルガノシラン類を加水分解してオルガノハイドロジェンポリシロキサン(一般式(2))を得、これに前記(i)式のポリオキシアルキレンと末端に二重結合を有するフッ素置換アルキル化合物を付加反応させて合成することができる。
<Synthesis Method 2>
R 1 3 SiX, R 1 2 SiX 2 , R 1 R 2 SiX 2 , R 1 R 3 SiX 2 , (R 1 ) (H) SiX 2 , (H) (R 1 ) 2 SiX, R 1 2 R 2 Selected from the group consisting of SiX and R 1 2 R 3 SiX (where X is a halogen such as Cl, Br or I or an alkoxy group such as methoxy, ethoxy or propoxy group), and (R 1 ) (H) An organosilane polysiloxane (general formula (2)) is obtained by hydrolyzing an organosilane having SiX 2 and / or (H) (R 1 ) 2 SiX as an essential component. And a fluorine-substituted alkyl compound having a double bond at the terminal can be synthesized by addition reaction.
尚、ここで上記オルガノシラン類を加水分解してからフッ素置換アルキル基を有するオルガノハイドロジェンシロキサン(一般式(3))を得て、これに前記(i)式のポリオキシアルキレンを付加反応させて合成しても良い。
また、上記オルガノシラン類を加水分解してからポリオキシアルキレン基を有するオルガノハイドロジェンシロキサン(一般式(4))を得、これに末端に二重結合を有するフッ素置換アルキル化合物を付加反応させて合成しても良い。
Here, after hydrolyzing the above organosilanes, an organohydrogensiloxane having a fluorine-substituted alkyl group (general formula (3)) is obtained, and this is reacted with the polyoxyalkylene of the above formula (i). May be synthesized.
Moreover, after hydrolyzing the organosilanes, an organohydrogensiloxane having a polyoxyalkylene group (general formula (4)) is obtained, and a fluorine-substituted alkyl compound having a double bond at the terminal is added to this. It may be synthesized.
さらには、一般式(5)で示されるフッ素ポリエーテル共変性シリコーンが、べたつきを抑え、すべり感を与える効果が高いため特に好ましい。この範囲に含まれる一般的な原料として、例えば、FPD−4668(信越化学工業社製)等が挙げられる。 Furthermore, the fluorine polyether co-modified silicone represented by the general formula (5) is particularly preferable because it has a high effect of suppressing stickiness and giving a feeling of slip. As a general raw material contained in this range, FPD-4668 (made by Shin-Etsu Chemical Co., Ltd.) etc. are mentioned, for example.
さらに本発明において(A)成分の含有量は、べたつきを抑え、すべり感の効果を良好に得るために、化粧水の総量を基準として0.01〜2質量%(以下単に%と示す)が好ましく、より好ましくは、0.1〜1%である。 Furthermore, in the present invention, the content of the component (A) is 0.01 to 2% by mass (hereinafter simply referred to as “%”) based on the total amount of the skin lotion in order to suppress stickiness and obtain a good feeling of slipping. Preferably, it is 0.1 to 1%.
本発明における(B)ジカルボン酸のエステルとしては、コハク酸,アジピン酸,セバシン酸,エイコサン二酸,テトラデカン二酸等のジカルボン酸と、オクチルドデカノール,ジエチルヘキサノール,ポリグリセリン等のアルコールとからなるエステルが例示され、それぞれ単独で、または2種以上を混合して用いることができる。 The ester of (B) dicarboxylic acid in the present invention comprises dicarboxylic acid such as succinic acid, adipic acid, sebacic acid, eicosane diacid, tetradecanedioic acid, and alcohol such as octyldodecanol, diethylhexanol, polyglycerin and the like. Examples are esters, and each can be used alone or in admixture of two or more.
これらの(B)成分の中でも、直鎖、分岐鎖、もしくは環状構造を含むジカルボン酸1種または2種以上とアルキレングリコールとのエステルである事が好ましい。さらにはジカルボン酸とアルキレングリコールとの質量平均分子量が5万未満であるオリゴマーエステルが好ましい。最も好ましいのは、ジカルボン酸としてエイコサン二酸とテトラデカン二酸、アルコールとしてポリグリセリンとから構成されるエステルであって、肌の潤い感の効果に最も優れている。市販品としては、例えば、Neosolue−Aqua(日本精化社製),KAK DIOS(高級アルコール工業社製),クロダモルDES(クローダジャパン社製)等が挙げられる。 Among these (B) components, esters of alkylene glycols with one or more dicarboxylic acids containing linear, branched or cyclic structures are preferred. Furthermore, the oligomer ester whose weight average molecular weight of dicarboxylic acid and alkylene glycol is less than 50,000 is preferable. Most preferred is an ester composed of eicosanedioic acid and tetradecanedioic acid as dicarboxylic acid and polyglycerin as alcohol, and has the most excellent effect of moisturizing skin. Examples of commercially available products include Neosolue-Aqua (manufactured by Nippon Seika Co., Ltd.), KAK DIOS (manufactured by Higher Alcohol Industry Co., Ltd.), Kurodamol DES (manufactured by Croda Japan), and the like.
本発明において(B)成分(純分)の含有量は、肌の潤い感の効果を良好に得るために、化粧水の総量を基準として0.01〜2%が好ましく、より好ましくは、0.1〜1%である。 In the present invention, the content of the component (B) (pure component) is preferably 0.01 to 2%, more preferably 0, based on the total amount of the lotion in order to obtain a good moisturizing effect. .1 to 1%.
本発明における(C)アルキレングリコールは、固体、液体といった性状にとらわれず、エチレングリコール、ジエチレングリコール、トリエチレングリコール、ポリエチレングリコール200、ポリエチレングリコール300、ポリエチレングリコール400、ポリエチレングリコール600、ポリエチレングリコール1000、ポリエチレングリコール1500、ポリエチレングリコール1540、ポリエチレングリコール2000、ポリエチレングリコール4000、ポリエチレングリコール6000、ポリエチレングリコール11000、ポリエチレングリコール20000、高重合ポリエチレングリコール、プロピレングリコール、ジプロピレングリコール、ポリプロピレングリコール、1,3ブチレングリコール、等が例示され、それぞれ単独、または2種以上を混合して用いることができる。これらの原料は、日油株式会社、ライオン株式会社、東邦化学工業株式会社等で容易に入手できる。 The (C) alkylene glycol in the present invention is not limited to properties such as solid and liquid, and is ethylene glycol, diethylene glycol, triethylene glycol, polyethylene glycol 200, polyethylene glycol 300, polyethylene glycol 400, polyethylene glycol 600, polyethylene glycol 1000, polyethylene glycol. 1500, polyethylene glycol 1540, polyethylene glycol 2000, polyethylene glycol 4000, polyethylene glycol 6000, polyethylene glycol 11000, polyethylene glycol 20000, highly polymerized polyethylene glycol, propylene glycol, dipropylene glycol, polypropylene glycol, 1,3 butylene glycol, etc. Is Can be used alone, or in combination of two or more. These raw materials can be easily obtained from NOF Corporation, Lion Corporation, Toho Chemical Industry Co., Ltd., etc.
これらの(C)成分の中でも、肌の潤い感の効果を良好に得るためには、ポリアルキレングリコール類が好ましく、特にポリエチレングリコール600、ポリエチレングリコール1000、ポリエチレングリコール1500、ポリエチレングリコール1540、ポリエチレングリコール2000、を使用することが好ましい。 Among these components (C), polyalkylene glycols are preferable in order to obtain a good moisturizing effect. Particularly, polyethylene glycol 600, polyethylene glycol 1000, polyethylene glycol 1500, polyethylene glycol 1540, polyethylene glycol 2000 are preferable. It is preferable to use.
本発明において(C)成分の含有量は、肌の潤い感の効果を得るために、化粧水の総量を基準として0.1〜10%が好ましく、より好ましくは、1〜5%である。 In the present invention, the content of the component (C) is preferably 0.1 to 10%, more preferably 1 to 5% based on the total amount of the lotion in order to obtain an effect of moisturizing the skin.
本発明に用いられる成分(D)の水は、通常、化粧料に配合することが可能な水であれば特に限定されず、例えば、精製水、温泉水、深層水、又は植物等の水蒸気蒸留水等が挙げられる。 The water of the component (D) used in the present invention is not particularly limited as long as it is usually water that can be blended in cosmetics. For example, purified water, hot spring water, deep water, or steam distillation of plants, etc. Water etc. are mentioned.
本発明における(D)成分の含有量は特に限定されるものではないが、本発明に用いられる(A)、(B)、(C)の種類や含有量に応じて、含有量を適宜調整する必要がある。 Although content of (D) component in this invention is not specifically limited, According to the kind and content of (A), (B), (C) used for this invention, content is adjusted suitably. There is a need to.
化粧品を商品的価値という点でみた場合に化粧品の外観は重要である。本発明化粧水は、外観的にもべたつきを感じさせないため、透明であることが好ましい。そこで、化粧水を構成する原料が水/アルコール(50%/50%)溶媒に対し、10%以上溶解する原料から構成することが好ましい。 The appearance of a cosmetic product is important when it is viewed in terms of commercial value. The skin lotion of the present invention is preferably transparent because it does not feel sticky in appearance. Therefore, it is preferable that the raw material constituting the skin lotion is composed of a raw material that dissolves 10% or more in water / alcohol (50% / 50%) solvent.
なお、ここでいう透明とは、島津UV−2550型分光光度計(島津製作所;吸収波長550nm,セル長1cm)で測定した光透過度が90%以上であることを指す。 The term “transparent” as used herein means that the light transmittance measured by Shimadzu UV-2550 type spectrophotometer (Shimadzu Corporation; absorption wavelength 550 nm, cell length 1 cm) is 90% or more.
また本発明の化粧水には、前記の各成分に加えて必要に応じて、かつ本発明の効果を損なわない範囲において、通常化粧品や医薬品等の皮膚外用剤に用いられる成分、例えば、抗老化薬剤、抗炎症剤、抗アンドロゲン剤、育毛剤、保湿剤、酸化防止剤、油性成分、紫外線吸収剤、界面活性剤、増粘剤、防腐剤、アルコール類、pH調整剤、洗浄剤、乾燥剤、乳化剤、粉末成分、色材、水性成分、各種毛髪栄養剤、香料、清涼剤、生薬抽出物やビタミン類等を必要に応じて適宜配合することができる。 In addition, in the lotion of the present invention, in addition to the above-described components, components that are usually used in skin external preparations such as cosmetics and pharmaceuticals, for example, anti-aging, as long as they do not impair the effects of the present invention. Drugs, anti-inflammatory agents, antiandrogens, hair restorers, moisturizers, antioxidants, oil components, UV absorbers, surfactants, thickeners, preservatives, alcohols, pH adjusters, cleaning agents, desiccants An emulsifier, a powder component, a colorant, an aqueous component, various hair nutrients, a fragrance, a refreshing agent, a herbal extract, vitamins, and the like can be appropriately blended as necessary.
その他、エデト酸二ナトリウム、エデト酸三ナトリウム、クエン酸ナトリウム、ポリリン酸ナトリウム、メタリン酸ナトリウム、グルコン酸等の金属封鎖剤、カフェイン、タンニン、ベラパミル、トラネキサム酸およびその誘導体、各種生薬、酢酸トコフェロール、グリチルリチン酸およびその誘導体またはその塩、グリチルレチン酸誘導体、サリチル酸誘導体、リゾフォスファチジルコリンやリゾフォスファチジン酸、大豆調製物等のラミニン5産生促進薬剤、グルコース、フルクトース、マンノース、ショ糖、トレハロース等の糖類、アルブチン、コウジ酸等の美白剤、ノニル酸ワレニルアミド、ニコチン酸ベンジルエステル、ニコチン酸β−ブトキシエチルエステル、カプサイシン、ジンゲロン、カンタリスチンキ、イクタモール、カフェイン、タンニン酸、α−ボルネオール、ニコチン酸トコフェロール、イノシトールヘキサニコチネート、シクランデレート、シンナリジン、トラゾリン、アセチルコリン、ベラパミル、セファランチン、γ−オリザノール等の血行促進剤、硫黄、チアントール等の抗脂漏剤、多様な目的から、ヒノキチオール、酸化亜鉛、アラントイン、ウコン抽出物、サイコ抽出物、イブキジャコウ抽出物、ヒオウギ抽出物、アセンヤク抽出物、ブナの芽抽出物、加水分解カゼイン、米抽出物加水分解液、米ぬか抽出物、トウニン抽出物、クララ抽出物、チオタウリン、ヒポタウリン、マジョラム抽出物、シリカ被覆酸化亜鉛、イチヤクソウ抽出物、キシリトール、アルギニン及びその塩酸塩、セリン、オウバク抽出成分、オウレン抽出成分、カッコン抽出成分、シコン抽出成分、シャクヤク抽出成分、センブリ抽出成分、バーチ抽出成分、セージ抽出成分、ビワ抽出成分、ニンジン抽出成分、アロエ抽出成分、ゼニアオイ抽出成分、アイリス抽出成分、ブドウ抽出成分、ヨクイニン抽出成分、ヘチマ抽出成分、ユリ抽出成分、サフラン抽出成分、センキュウ抽出成分、ショウキョウ抽出成分、オトギリソウ抽出成分、ローズマリー抽出成分、ニンニク抽出成分、トウガラシ抽出成分、ワレモコウ抽出成分、チンピ、トウキ等、レチノール、酢酸レチノール等のビタミンA類、リボフラビン、酪酸リボフラビン、フラビンアデニンヌクレオチド等のビタミンB2類、ピリドキシン塩酸塩、ピリドキシンジオクタノエート等のビタミンB2類、L−アスコルビン酸、L−アスコルビン酸ジパルミチン酸エステル、L−アスコルビン酸−2−硫酸ナトリウム、L−アスコルビン酸リン酸エステル、DL−α−トコフェロール−L−アスコルビン酸リン酸ジエステルジカリウム等のビタミンC類、パントテン酸カルシウム、D−パントテニルアルコール、パントテニルエチルエーテル、アセチルパントテニルエチルエーテル等のパントテン酸類、エルゴカルシフェロール、コレカルシフェロール等のビタミンD類、ニコチン酸、ニコチン酸アミド、ニコチン酸ベンジル等のニコチン酸類、α−トコフェロール、酢酸トコフェロール、ニコチン酸DL−α−トコフェロール、コハク酸DL−α−トコフェロール等のビタミンE類、ビタミンP、ビオチン等のビタミン類なども適宜配合することができる。 In addition, edetate disodium, edetate trisodium, sodium citrate, sodium polyphosphate, sodium metaphosphate, gluconic acid sequestering agents, caffeine, tannin, verapamil, tranexamic acid and its derivatives, various herbal medicines, tocopherol acetate , Glycyrrhizic acid and its derivatives or salts thereof, glycyrrhetinic acid derivatives, salicylic acid derivatives, lysophosphatidylcholine, lysophosphatidic acid, laminin 5 production promoting agents such as soybean preparation, glucose, fructose, mannose, sucrose, trehalose Sugars such as arbutin, kojic acid, nonyl acid valenylamide, nicotinic acid benzyl ester, nicotinic acid β-butoxyethyl ester, capsaicin, gingerone, cantalis tincture, ictamol Aein, tannic acid, α-borneol, tocopherol nicotinate, inositol hexanicotinate, cyclandrate, cinnarizine, tolazoline, acetylcholine, verapamil, cephalanthin, γ-oryzanol and other anti-seborrheic agents such as sulfur and thianthol For various purposes, Hinokitiol, Zinc oxide, Allantoin, Turmeric extract, Psycho extract, Ibuki extract, Hagigi extract, Acacia extract, Beech bud extract, Hydrolytic casein, Rice extract hydrolyzed solution , Rice bran extract, Tonin extract, Clara extract, Thiotaurine, Hipotaurine, Marjoram extract, Silica-coated zinc oxide, Ichiyakusu extract, Xylitol, Arginine and its hydrochloride, Serine, Oat extract component, Auren extract component, Cuckold extract Ingredients, sicon extract components, peony extract components, assembly extract components, birch extract components, sage extract components, loquat extract components, carrot extract components, aloe extract components, mallow extract components, iris extract components, grape extract components, yakuin extract components, Loofah extract, lily extract, saffron extract, nematode extract, ginger extract, hypericum extract, rosemary extract, garlic extract, capsicum extract, bitumen extract, chimpi, touki, etc., retinol, acetic acid Vitamin A such as retinol, vitamin B2 such as riboflavin, riboflavin butyrate, flavin adenine nucleotide, vitamin B2 such as pyridoxine hydrochloride, pyridoxine dioctanoate, L-ascorbic acid, dipalmitin L-ascorbate Vitamin C such as acid ester, L-ascorbic acid-2-sodium sulfate, L-ascorbic acid phosphate, DL-α-tocopherol-L-ascorbic acid diester dipotassium, calcium pantothenate, D-pantothenyl alcohol , Pantothenic acid such as pantothenyl ethyl ether and acetyl pantothenyl ethyl ether, vitamin D such as ergocalciferol and cholecalciferol, nicotinic acid such as nicotinic acid, nicotinamide, and benzyl nicotinate, α-tocopherol, tocopherol acetate Vitamin E such as DL-α-tocopherol nicotinate and DL-α-tocopherol succinate, vitamins such as vitamin P and biotin, and the like can be appropriately blended.
以下、実施例により本発明を具体的に説明するが、これらの実施例により本発明の技術範囲が限定されるものではない。尚、実施例に記載の官能試験(塗布時のべたつき、潤い感、なめらか感、すべり感、効果の持続性)、保存安定性、透明性に関する試験法を下記に示す。 EXAMPLES Hereinafter, although an Example demonstrates this invention concretely, the technical scope of this invention is not limited by these Examples. In addition, the sensory test (the stickiness at the time of application | coating, a moist feeling, a smooth feeling, a slipperiness, the sustainability of an effect), the storage stability, and the test method regarding transparency are shown below.
(1)官能試験 20名の専門パネルを対象に実施例および比較例の化粧水を使用してもらい、塗布時のべたつき、潤い感、なめらか感、すべり感、効果の持続性について官能試験を行い、下記に示す判定基準により評価を行った。
判定基準
塗布時のべたつき
◎:パネルの15名以上がべたつきがないと判断
○:パネルの10名以上15名未満がべたつきがないと判断
△:パネルの5名以上10名未満がべたつきがないと判断
×:パネルの5名未満がべたつきがないと判断
潤い感
◎:パネルの15名以上が潤い感があると判断
○:パネルの10名以上15名未満が潤い感があると判断
△:パネルの5名以上10名未満が潤い感があると判断
×:パネルの5名未満が潤い感があると判断
なめらか感
◎:パネルの15名以上がなめらか感があると判断
○:パネルの10名以上15名未満がなめらか感があると判断
△:パネルの5名以上10名未満がなめらか感があると判断
×:パネルの5名未満がなめらか感があると判断
すべり感
◎:パネルの15名以上がすべり感が良いと判断
○:パネルの10名以上15名未満がすべり感が良いと判断
△:パネルの5名以上10名未満がすべり感が良いと判断
×:パネルの5名未満がすべり感が良いと判断
効果の持続性
◎:パネルの15名以上が効果が持続すると判断
○:パネルの10名以上15名未満が効果が持続すると判断
△:パネルの5名以上10名未満が効果が持続すると判断
×:パネルの5名未満が効果が持続すると判断
(1) Sensory test Targeting 20 professional panels using the lotions of the examples and comparative examples, and performing a sensory test on stickiness, moisture, smoothness, slipperiness, and sustainability of effects during application. Evaluation was performed according to the following criteria.
Judgment criteria Stickiness at the time of application ◎: More than 15 people on the panel are judged not sticky ○: More than 10 people and less than 15 people on the panel are judged not sticky △: More than 5 people and less than 10 people on the panel are not sticky Judgment X: Judgment that less than 5 panel members are not sticky Moist feeling ◎: Judging that 15 panel members or more have moist feeling O: Judging that 10 to 15 panel members have moist feeling △: Panel No less than 5 and less than 10 people have a feeling of moisture ×: Less than 5 people on the panel have a feeling of moisture Smoothness ◎: More than 15 people on the panel have a feeling of smoothness ○: 10 people on the panel More than 15 people are judged to have a smooth feeling. △: More than 5 and less than 10 people on the panel are judged to have a smooth feeling. X: Less than 5 people on the panel are judged to have a smooth feeling. The above is slippery Judged as good ○: More than 10 and less than 15 panelists judged that slipperiness was good △: More than 5 and less than 10 panelists judged that slipperiness was good ×: Less than 5 panelists felt slippery Judgment Sustained effect ◎: More than 15 panelists determine that the effect will continue ○: More than 10 panelists and less than 15 will be effective △: More than 5 and less than 10 panelists will continue to be effective X: Less than 5 panelists judged that the effect would last
(2)保存安定性
実施例および比較例の化粧水を100mLの透明ガラス製容器に入れて密封し、45℃の恒温槽ならびに往復恒温槽(5℃〜30℃のサイクル恒温槽)に1ヶ月保存し、下記の視覚判定基準で評価を行い、いずれの恒温槽での評価のうち、低い方の評価を保存安定性の評価として採用した。
○:外観の変化が全くなく、透明性の低下や澱などが観察されない。
△:僅かに透明性の低下や澱が認められる。
×:明らかに白濁や澱が認められる。
(2) Storage stability The skin lotion of Examples and Comparative Examples is sealed in a 100 mL transparent glass container, and stored in a 45 ° C. constant temperature bath and a reciprocating thermostatic bath (5 ° C. to 30 ° C. cycle constant temperature bath) for 1 month. It preserve | saved and evaluated by the following visual criteria, and the evaluation of the lower one was employ | adopted as an evaluation of storage stability among the evaluation in any thermostat.
○: No change in appearance, no decrease in transparency or starch is observed.
Δ: Slight decrease in transparency and starch are observed.
X: Clear cloudiness and starch are recognized.
(3)透明性
実施例および比較例の化粧水を島津UV−2550型分光光度計(島津製作所;吸収波長550nm,セル長1cm)で測定し、その光透過度により下記の基準で評価を行なった。
◎:光透過度が95%以上
○:光透過度が90%以上95%未満
×:光透過度が90%未満
(3) Transparency The lotions of Examples and Comparative Examples were measured with Shimadzu UV-2550 type spectrophotometer (Shimadzu Corporation; absorption wavelength 550 nm, cell length 1 cm), and evaluation was performed according to the following criteria based on the light transmittance. It was.
◎: Light transmittance is 95% or more ○: Light transmittance is 90% or more and less than 95% ×: Light transmittance is less than 90%
表1に示す実施例1〜9、比較例1〜5の化粧水を常法に従って作成し、前記の諸試験を実施して評価を行った。その結果を併せて表1に示す。ただし、実施例、比較例で使用した※1ポリオキシエチレン・パーフルオロポリシロキサン(一般式(6))は、FPD−4668(信越化学工業社製)、※2ポリオキシエチレン・メチルポリシロキサン(一
般式(7))には、SS−2804(東レ・ダウコーニング社製)、※3(エイコサン二酸/テトラデカン二酸)ポリグリセリル−10には、Neosolue−Aqua(日本精化社製)を使用した。
The lotions of Examples 1 to 9 and Comparative Examples 1 to 5 shown in Table 1 were prepared according to a conventional method, and the above tests were carried out for evaluation. The results are also shown in Table 1. However, * 1 polyoxyethylene perfluoropolysiloxane (general formula (6)) used in Examples and Comparative Examples is FPD-4668 (manufactured by Shin-Etsu Chemical Co., Ltd.), * 2 polyoxyethylene methylpolysiloxane ( For general formula (7), SS-2804 (manufactured by Dow Corning Toray) * 3 (eicosandioic acid / tetradecanedioic acid) Polyglyceryl-10 uses Neosole-Aqua (manufactured by Nippon Seika Co., Ltd.) did.
表1から明らかなように、本発明の化粧水は、比較例と比べて明らかに官能試験(塗布時のべたつき、潤い感、なめらか感、すべり感、効果の持続性)、保存安定性、透明性に関する試験のいずれの評価においても優れていた。 As is clear from Table 1, the lotion of the present invention clearly has a sensory test (stickiness during application, moist feeling, smooth feeling, slipperiness, durability of effect), storage stability, and transparency as compared with the comparative example. It was excellent in all evaluations of the test on sex.
以下、本発明化粧水のその他の処方例を実施例として挙げる。なお、これらの実施例の化粧水についても、上記の官能試験(塗布時のべたつき、潤い感、なめらか感、すべり感、効果の持続性)、保存安定性、透明性を検討したところ、いずれの実施例においても、優れた特性を有しており良好であった。なお、実施例中で使用したポリオキシエチレン・パーフルオロポリシロキサン及びポリオキシエチレン・メチルポリシロキサンは、表1と同じ化合物を使用した。 Hereinafter, other prescription examples of the skin lotion of the present invention will be given as examples. In addition, for the lotions of these examples, the above-mentioned sensory test (stickiness at application, moist feeling, smooth feeling, slipperiness, durability of effect), storage stability, and transparency were examined. Also in the examples, it had excellent characteristics and was good. In addition, the same compound as Table 1 was used for the polyoxyethylene perfluoropolysiloxane and the polyoxyethylene methylpolysiloxane used in the Example.
実施例10 化粧水(さっぱり)
以下に記載の配合組成の化粧水を常法により調製し、化粧水(さっぱり)を得た。
(質量%)
1.ポリオキシエチレン・パーフルオロポリシロキサン・・・(A) 0.2
[FPD−4668(信越化学工業社製)]
2.ポリオキシエチレン・メチルポリシロキサン・・・(A) 0.1
[SS−2802(東レ・ダウコーニング社製)]
3.(エイコサン二酸/テトラデカン二酸)・・・(B) 0.2
ポリグリセリル−10 (純分換算:0.12)
[Neosolue−Aqua(日本精化社製)]
4.ポリエチレングリコール1000・・・(C) 1.0
5.PEG−60水添ヒマシ油 0.8
6.リン酸一カリウム 0.08
7.リン酸二ナトリウム 0.02
8.ジメチルシラノールヒアルロネート 0.001
9.ローヤルゼリーエキス 0.3
10.加水分解シルク 0.1
11.アロエエキス 0.1
12.キューカンバーエキス 0.1
13.香料 0.3
14.エタノール 40.0
15.精製水・・・(D) 残 部
Example 10 lotion (fresh)
A lotion having the composition described below was prepared by a conventional method to obtain a lotion (fresh).
(mass%)
1. Polyoxyethylene / perfluoropolysiloxane (A) 0.2
[FPD-4668 (manufactured by Shin-Etsu Chemical Co., Ltd.)]
2. Polyoxyethylene methylpolysiloxane (A) 0.1
[SS-2802 (manufactured by Toray Dow Corning)]
3. (Eicosane diacid / tetradecanedioic acid) (B) 0.2
Polyglyceryl-10 (Pure equivalent: 0.12)
[Neosol-Aqua (made by Nippon Seika Co., Ltd.)]
4). Polyethylene glycol 1000 (C) 1.0
5). PEG-60 hydrogenated castor oil 0.8
6). Monopotassium phosphate 0.08
7). Disodium phosphate 0.02
8). Dimethylsilanol hyaluronate 0.001
9. Royal Jelly Extract 0.3
10. Hydrolyzed silk 0.1
11. Aloe extract 0.1
12 Cucumber extract 0.1
13. Fragrance 0.3
14 Ethanol 40.0
15. Purified water ... (D) Remainder
実施例11 化粧水(しっとり)
以下に記載の配合組成の化粧水を常法により調製し、化粧水(しっとり)を得た。
(質量%)
1.ポリオキシエチレン・パーフルオロポリシロキサン・・・(A) 0.3
[FPD−4668(信越化学工業社製)]
2.コハク酸ジエトキシエチル・・・(B) 0.2
[クロダモルDES(クローダジャパン社製)]
3.ポリエチレングリコール1000・・・(C) 1.0
4.グリセリン 2.0
5.PEG−60水添ヒマシ油 0.3
6.メチルパラベン 0.1
7.加水分解コンキオリン 0.1
8.ツバキ種子抽出物 0.05
9.精製ハチミツ 0.1
10.マテ茶エキス 0.1
11.ヨクイニンエキス 0.1
12.ローヤルゼリーエキス 0.1
13.エタノール 10.0
14.精製水・・・(D) 残 部
Example 11 Lotion (Moist)
A lotion having the composition described below was prepared by a conventional method to obtain a lotion (moisture).
(mass%)
1. Polyoxyethylene / perfluoropolysiloxane (A) 0.3
[FPD-4668 (manufactured by Shin-Etsu Chemical Co., Ltd.)]
2. Diethoxyethyl succinate (B) 0.2
[Kurodamol DES (manufactured by Croda Japan)]
3. Polyethylene glycol 1000 (C) 1.0
4). Glycerin 2.0
5). PEG-60 hydrogenated castor oil 0.3
6). Methylparaben 0.1
7). Hydrolyzed conchiolin 0.1
8). Camellia seed extract 0.05
9. Purified honey 0.1
10. Mate tea extract 0.1
11. Yokuinin extract 0.1
12 Royal Jelly Extract 0.1
13. Ethanol 10.0
14 Purified water ... (D) The rest
実施例12 ボディミスト
以下に記載の配合組成で常法により調製し、エアゾール缶に充填し、窒素にて0.6MPaに加圧し、エアゾールスプレー状の化粧水を得た。
(質量%)
1.ポリオキシエチレン・パーフルオロポリシロキサン・・・(A) 0.3
[FPD−4668(信越化学工業社製)]
2.(エイコサン二酸/テトラデカン二酸)・・・(B) 0.2
ポリグリセリル−10 (純分換算:0.12)
[Neosolue−Aqua(日本精化社製)]
3.ポリエチレングリコール1500・・・(C) 2.0
4.PEG−60水添ヒマシ油 0.01
5.ジメチルシラノールヒアルロネート 0.001
6.ローヤルゼリーエキス 0.1
7.豆乳発酵液 0.1
8.タチジャコウソウエキス 0.1
9.エタノール 15.0
10.精製水・・・(D) 残 部
Example 12 Body Mist Prepared by a conventional method with the composition described below, filled into an aerosol can, and pressurized to 0.6 MPa with nitrogen to obtain an aerosol spray lotion.
(mass%)
1. Polyoxyethylene / perfluoropolysiloxane (A) 0.3
[FPD-4668 (manufactured by Shin-Etsu Chemical Co., Ltd.)]
2. (Eicosane diacid / tetradecanedioic acid) (B) 0.2
Polyglyceryl-10 (Pure equivalent: 0.12)
[Neosol-Aqua (made by Nippon Seika Co., Ltd.)]
3. Polyethylene glycol 1500 (C) 2.0
4). PEG-60 hydrogenated castor oil 0.01
5). Dimethylsilanol hyaluronate 0.001
6). Royal Jelly Extract 0.1
7). Soymilk fermentation broth 0.1
8). Tachikaku extract 0.1
9. Ethanol 15.0
10. Purified water ... (D) Remainder
上記実施例10で使用した香料は表2に示すものである。 The fragrance used in Example 10 is shown in Table 2.
以上記載の如く、本発明はべたつきがなく、肌の潤い感、なめらか感、すべり感に優れ、かつその効果が長時間持続する、透明性に優れた化粧水を提供できる。 As described above, the present invention can provide a skin lotion having excellent transparency, having no stickiness, excellent moisturizing feeling, smooth feeling, and smooth feeling, and the effect lasting for a long time.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008228041A JP5329157B2 (en) | 2008-09-05 | 2008-09-05 | Lotion |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008228041A JP5329157B2 (en) | 2008-09-05 | 2008-09-05 | Lotion |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2010059117A true JP2010059117A (en) | 2010-03-18 |
JP5329157B2 JP5329157B2 (en) | 2013-10-30 |
Family
ID=42186362
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008228041A Expired - Fee Related JP5329157B2 (en) | 2008-09-05 | 2008-09-05 | Lotion |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5329157B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011065123A1 (en) * | 2009-11-30 | 2011-06-03 | 株式会社資生堂 | Cosmetic |
JP2017014143A (en) * | 2015-06-30 | 2017-01-19 | 花王株式会社 | Transparent cosmetic |
JP2017081879A (en) * | 2015-10-30 | 2017-05-18 | 花王株式会社 | Transparent cosmetic |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05229928A (en) * | 1992-02-24 | 1993-09-07 | Kao Corp | Toilet water |
JP2002255729A (en) * | 2001-03-01 | 2002-09-11 | Chifure Keshohin:Kk | Cosmetic |
JP2007126359A (en) * | 2005-10-31 | 2007-05-24 | Dow Corning Toray Co Ltd | Skin cosmetic |
JP2007137847A (en) * | 2005-11-22 | 2007-06-07 | Nippon Fine Chem Co Ltd | Oligomer ester, cosmetic and external preparation for skin containing the same |
-
2008
- 2008-09-05 JP JP2008228041A patent/JP5329157B2/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05229928A (en) * | 1992-02-24 | 1993-09-07 | Kao Corp | Toilet water |
JP2002255729A (en) * | 2001-03-01 | 2002-09-11 | Chifure Keshohin:Kk | Cosmetic |
JP2007126359A (en) * | 2005-10-31 | 2007-05-24 | Dow Corning Toray Co Ltd | Skin cosmetic |
JP2007137847A (en) * | 2005-11-22 | 2007-06-07 | Nippon Fine Chem Co Ltd | Oligomer ester, cosmetic and external preparation for skin containing the same |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011065123A1 (en) * | 2009-11-30 | 2011-06-03 | 株式会社資生堂 | Cosmetic |
JP2017014143A (en) * | 2015-06-30 | 2017-01-19 | 花王株式会社 | Transparent cosmetic |
JP2017081879A (en) * | 2015-10-30 | 2017-05-18 | 花王株式会社 | Transparent cosmetic |
Also Published As
Publication number | Publication date |
---|---|
JP5329157B2 (en) | 2013-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101387209B1 (en) | Silicone-organic elastomer gels | |
KR101364818B1 (en) | Silicone elastomer gels | |
JP6980474B2 (en) | Aqueous cleansing cosmetics | |
KR20080108558A (en) | Silicone polyether elastomer gels | |
KR20150103138A (en) | Skin-exterior anti-ageing composition and production method therefor | |
JP2020132631A (en) | External skin composition | |
JP2007051078A (en) | Non-aqueous hair cosmetic | |
JP2019131547A (en) | Aqueous composition | |
JPWO2014115726A1 (en) | Antibacterial composition | |
JP5329157B2 (en) | Lotion | |
TWI311913B (en) | ||
JP2020117500A (en) | External composition for skin | |
US8192726B1 (en) | Naturally derived citrate polyesters having liquid and solid domains | |
JP5416559B2 (en) | Hair cosmetics | |
CN105189430A (en) | High-purity monoalkenyl-containing glycerin derivative, and method for producing same | |
JP2010132568A (en) | Hair cosmetic | |
KR101441360B1 (en) | Oily cleansing cosmetic composition | |
JP5961072B2 (en) | Cleansing cosmetics | |
JP2012214418A (en) | Composition for external use | |
JP5002433B2 (en) | Hair cosmetics | |
JP2016117673A (en) | Foamy cosmetic | |
JP6273117B2 (en) | Liquid cosmetics | |
JP2008189639A (en) | Nonaqueous hair cosmetic | |
JP6010307B2 (en) | Aqueous cosmetics | |
JP2021116262A (en) | Transparent gel composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110624 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20110624 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20121017 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20121127 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130123 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130716 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130724 |
|
R151 | Written notification of patent or utility model registration |
Ref document number: 5329157 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |